| Ticker | DVAX |
|---|---|
| ISIN | US2681582019 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limit...
El precio actual de Dynavax Technologies Corporation (DVAX) es de 15,50 , con una variación del 0,00%.
Dynavax Technologies Corporation opera en el sector Healthcare, industria Drug Manufacturers - Specialty & Generic.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones